By proposing a new safe harbor for patient engagement tools and creating three new safe harbors for value-based arrangements, the Department of Health and Human Services Office of Inspector General has taken “the first steps toward much needed reform” of the federal anti-kickback statute and civil monetary penalty rules regarding beneficiary inducements, AHA told the agency in comments submitted today. While aspects of the rule provide a “crucial foundation” for transformation in health care, AHA said OIG “can — and should — do more to remove the barriers presented by outdated AKS rules and open the way to a value-based system. The most pressing improvement needed in the final rule is to create a robust safe harbor for non-risk value-based arrangements, modeled on [the Centers for Medicare & Medicaid Services’] proposed exception for the same type of arrangements.” In finalizing the rule, OIG should “adapt its proposed safe harbors to protect a broader universe of the innovative, value-based arrangements made possible by the CMS exceptions,” the association said.

Headline
The AHA May 27 filed an amicus brief in the 7th U.S. Circuit Court of Appeals supporting the dismissal of an online tracking lawsuit against a member hospital…
Chairperson's File
Public
We’re at a watershed moment in health care, which gives us opportunities to strengthen how we serve patients and communities. Health care leaders must help…
Perspective
Public
This week, more than 1,000 hospital and health system leaders came to Washington, D.C., united by a shared responsibility: to ensure every community has access…
Chairperson's File
Public
More than 1,000 leaders from hospitals and health systems across the country will gather in Washington, D.C., early next week at the 2026 AHA Annual…
Headline
The AHA will host a webinar April 16 at 1 p.m. ET featuring leaders from CHRISTUS Health and The Urology Group to share how nurse-first triage and smarter…
Headline
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…